Johan Bussink

21.7k total citations · 6 hit papers
244 papers, 16.3k citations indexed

About

Johan Bussink is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Johan Bussink has authored 244 papers receiving a total of 16.3k indexed citations (citations by other indexed papers that have themselves been cited), including 101 papers in Cancer Research, 87 papers in Pulmonary and Respiratory Medicine and 84 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Johan Bussink's work include Cancer, Hypoxia, and Metabolism (95 papers), Medical Imaging Techniques and Applications (55 papers) and Lung Cancer Diagnosis and Treatment (44 papers). Johan Bussink is often cited by papers focused on Cancer, Hypoxia, and Metabolism (95 papers), Medical Imaging Techniques and Applications (55 papers) and Lung Cancer Diagnosis and Treatment (44 papers). Johan Bussink collaborates with scholars based in Netherlands, United States and Germany. Johan Bussink's co-authors include Johannes H.A.M. Kaanders, Albert J. van der Kogel, Paul N. Span, Philippe Lambin, Hugo J.W.L. Aerts, Chintan Parmar, Patrick Großmann, Ralph T. H. Leijenaar, Robert J. Gillies and John Quackenbush and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Investigation and Nature Communications.

In The Last Decade

Johan Bussink

236 papers receiving 16.2k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach

2014 3.6k citations Hugo J.W.L. Aerts, Chintan Parmar et al. profile →
Machine Learning methods for Quantitative Radiomic Biomarkers

2015 746 citations Chintan Parmar, Patrick Großmann et al. profile →
The unfolded protein response protects human tumor cells during hypoxia through regulation of the autophagy genes MAP1LC3B and ATG5

2009 654 citations Kasper M.A. Rouschop, Johan Bussink et al. profile →
Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study

2018 398 citations Ahmed Hosny, Chintan Parmar et al. PLoS Medicine profile →
Radiomic feature clusters and Prognostic Signatures specific for Lung and Head & Neck cancer

2015 358 citations Chintan Parmar, Patrick Großmann et al. profile →
Exploratory Study to Identify Radiomics Classifiers for Lung Cancer Histology

2016 299 citations Chintan Parmar, Patrick Großmann et al. profile →

Peers

Countries citing papers authored by Johan Bussink

Since Specialization

Citations

This map shows the geographic impact of Johan Bussink's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Johan Bussink with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Johan Bussink more than expected).

Fields of papers citing papers by Johan Bussink

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Johan Bussink. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Johan Bussink. The network helps show where Johan Bussink may publish in the future.

Co-authorship network of co-authors of Johan Bussink

This figure shows the co-authorship network connecting the top 25 collaborators of Johan Bussink. A scholar is included among the top collaborators of Johan Bussink based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Johan Bussink. Johan Bussink is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Mitochondria Targeting of Oxidative Phosphorylation Inhibitors to Alleviate Hypoxia and Enhance Anticancer Treatment Efficacy 2025 ·Clinical Cancer Research ·(unknown), Sandra Heskamp, (unknown), Gosse J. Adema, Paul N. Span, Johan Bussink	7
2	Multicollinearity and redundancy of the PET radiomic feature set 2025 ·European Radiology ·(unknown), Dennis Vriens, Johan Bussink, Tineke W.H. Meijer, Erik H.J.G. Aarntzen, Christophe M. Deroose, Renaud Lhommel, Nicolas Aide, Christophe Le Tourneau, (unknown), Wim J.G. Oyen, (unknown), Jelle P. Ruurda, Erik Vegt, Lioe‐Fee de Geus‐Oei, Floris H. P. van Velden	0
3	The potential of targeted radionuclide therapy to treat hypoxic tumor cells 2024 ·Nuclear Medicine and Biology ·(unknown), Sanne A. M. van Lith, (unknown), (unknown), Johan Bussink, (unknown)	2
4	MitoTam induces ferroptosis and increases radiosensitivity in head and neck cancer cells 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), Gosse J. Adema, Wenny J.M. Peeters, Jiřı́ Neužil, Jan Štursa, Lukáš Werner, Fred C.G.J. Sweep, Johan Bussink, Paul N. Span	5
5	Cancer-associated fibroblasts, tumor and radiotherapy: interactions in the tumor micro-environment 2024 ·Journal of Experimental & Clinical Cancer Research ·(unknown), Gosse J. Adema, Johan Bussink, Marleen Ansems	21
6	779: Risk of left ventricular dysfunction after thoracic irradiation 2024 ·Radiotherapy and Oncology ·(unknown), (unknown), Robin Wijsman, (unknown), Johan Bussink, Anthonie L. Duijnhouwer, Tineke P. Willems, Elke S. Hoendermis, Johannes A. Langendijk, Christina T. Muijs, Peter van Luijk	0
7	ATG12 deficiency results in intracellular glutamine depletion, abrogation of tumor hypoxia and a favorable prognosis in cancer 2021 ·Autophagy ·Tom G. Keulers, Alexander Koch, Marike W. van Gisbergen, (unknown), Marijke I. Zonneveld, Monique C. de Jong, Kim G.M. Savelkouls, (unknown), Johan Bussink, Veerle Melotte, Kasper M.A. Rouschop	24
8	The Influence of the Exclusion of Central Necrosis on [18F]FDG PET Radiomic Analysis 2021 ·Diagnostics ·(unknown), Dennis Vriens, (unknown), Cornelis H. Slump, Erik H.J.G. Aarntzen, Anouk van Berkel, Henri Timmers, Johan Bussink, Tineke W.H. Meijer, Lioe‐Fee de Geus‐Oei, Floris H. P. van Velden	6
9	Genotyping and Characterization of HPV Status, Hypoxia, and Radiosensitivity in 22 Head and Neck Cancer Cell Lines 2021 ·Cancers ·(unknown), Marleen Ansems, William P. J. Leenders, Johan Bussink, Paul N. Span	11
10	Radiotherapy and cGAS/STING signaling: Impact on MDSCs in the tumor microenvironment 2021 ·Cellular Immunology ·(unknown), (unknown), Paul N. Span, Johan Bussink, Gosse J. Adema	56
11	Adding the temporal domain to PET radiomic features 2020 ·PLoS ONE ·(unknown), Dennis Vriens, Cornelis H. Slump, Johan Bussink, Tineke W.H. Meijer, Lioe‐Fee de Geus‐Oei, Floris H. P. van Velden	13
12	Interferon-Stimulated Genes Are Involved in Cross-resistance to Radiotherapy in Tamoxifen-Resistant Breast Cancer 2018 ·Clinical Cancer Research ·(unknown), Marcel Smid, Anika Nagelkerke, John W.M. Martens, Johan Bussink, Fred C.G.J. Sweep, Paul N. Span	64
13	PD-L1 microSPECT/CT Imaging for Longitudinal Monitoring of PD-L1 Expression in Syngeneic and Humanized Mouse Models for Cancer 2018 ·Cancer Immunology Research ·Sandra Heskamp, (unknown), Janneke D.M. Molkenboer‐Kuenen, (unknown), Soley Thordardottir, Jeannette Cany, Daniel Olive, Johan Bussink, Otto C. Boerman, Harry Dolstra, Erik H.J.G. Aarntzen, Willemijn Hobo	30
14	Improved Evaluation of Antivascular Cancer Therapy Using Constrained Tracer-Kinetic Modeling for Multiagent Dynamic Contrast-Enhanced MRI 2018 ·Cancer Research ·Stefanie J. Hectors, Igor Jacobs, Jasper Lok, Johannes Peters, Johan Bussink, Freek J. M. Hoeben, Henk M. Keizer, Henk M. Janssen, Klaas Nicolay, Matthias C. Schabel, Gustav J. Strijkers	14
15	Deep learning for lung cancer prognostication: A retrospective multi-cohort radiomics study breakdown → 2018 ·PLoS Medicine ·Ahmed Hosny, Chintan Parmar, Thibaud Coroller, Patrick Großmann, Roman Zeleznik, (unknown), Johan Bussink, Robert J. Gillies, Raymond H. Mak, Hugo J.W.L. Aerts	398
16	Improved Recurrence-Free Survival with ARCON for Anemic Patients with Laryngeal Cancer 2014 ·Clinical Cancer Research ·Geert O. Janssens, Saskia E. Rademakers, Chris H.J. Terhaard, Patricia Doornaert, Hendrik P. Bijl, Piet van den Ende, Alim Chin, Robert P. Takes, Remco de Bree, Ilse J. Hoogsteen, Johan Bussink, Paul N. Span, J.H.A.M. Kaanders	29
17	Vascular responses to radiotherapy and androgen-deprivation therapy in experimental prostate cancer 2012 ·Radiation Oncology ·Kathrine Røe, (unknown), Albert J. van der Kogel, Johan Bussink, Heidi Lyng, Anne Hansen Ree, Laure Marignol, Dag Rune Olsen	23
18	Augmentation of Radiation Response by Motesanib, a Multikinase Inhibitor that Targets Vascular Endothelial Growth Factor Receptors 2010 ·Clinical Cancer Research ·Tim J. Kruser, Deric L. Wheeler, Eric A. Armstrong, Mari Iida, Kevin R. Kozak, Albert J. van der Kogel, Johan Bussink, Angela Coxon, Anthony Polverino, Paul M. Harari	13
19	Hypoxic cell turnover in different solid tumor lines 2005 ·International Journal of Radiation OncologyBiologyPhysics ·Anna Ljungkvist, Johan Bussink, Johannes H.A.M. Kaanders, Paulus F.J.W. Rijken, Adrian C. Begg, James A. Raleigh, Albert J. van der Kogel	70
20	Repair of chromosome and DNA breaks versus cell survival in Chinese hamster cells 1996 ·International Journal of Radiation Biology ·Johan Bussink	9

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact